Ypsomed Holding AG

Swiss Stock Exchange:YPSN.SW

Sector

🏥 Health Care

Industries

💊 Drugstores & Retail Pharmacies

💳 Credit Cards & Payments

🩺 Medical Instruments

💊 Pharmaceuticals

🛍 Specialty Retail

Location

Switzerland

Market Cap

USD 6.70 B

Share Price

USD 490.82

Avg Daily Volume

16,464

Change (1 day)

0.31%

Change (1 year)

10.58%

Change (YTD)

35.54%

Ypsomed Holding AG Return on Equity (ROE) for the year ending March 31, 2024: 12.69%

Ypsomed Holding AG Return on Equity (ROE) is 12.69% for the year ending March 31, 2024, a 39.13% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.

Ypsomed Holding AG Return on Equity (ROE) for the year ending March 31, 2023 was 9.12%, a 54.91% change year over year.
Ypsomed Holding AG Return on Equity (ROE) for the year ending March 31, 2022 was 5.89%, a 300.49% change year over year.
Ypsomed Holding AG Return on Equity (ROE) for the year ending March 31, 2021 was 1.47%, a -52.70% change year over year.
Ypsomed Holding AG Return on Equity (ROE) for the year ending March 31, 2020 was 3.11%, a -80.43% change year over year.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	Return on Equity (ROE)	Return on Assets (ROA)	Revenue Per Share	Free Cash Flow Per Share

Swiss Stock Exchange: YPSN.SW

Ypsomed Holding AG

CEO	Mr. Simon Michel
IPO Date	Sept. 22, 2004
Location	Switzerland
Headquarters	Brunnmattstrasse 6
Employees	2,600
Sector	🏥 Health Care
Industries Drugstores & Retail Pharmacies 💳 Credit Cards & Payments 🩺 Medical Instruments 💊 Pharmaceuticals 🛍 Specialty Retail

Description

Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies. The company operates in two segments, Ypsomed Delivery Systems and Ypsomed Diabetes Care. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto injectors, patch injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories, and other day-to-day items for diabetics. This segment offers its products under the mylife brand name. The company offers precision turned parts; and contract manufacturing and other services. It markets its products through biotechnology and pharmaceutical partners, as well as through its own distribution network and independent distributors. It operates in Switzerland, Europe, North America, and internationally. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.